Amneal Pharmaceuticals Inc. share price logo

Amneal Pharmaceuticals Inc. Share Price

NYSE: AMRX

Mid Cap

$12.86

+0.14

(+1.14%)

Live

as on

Amneal Pharmaceuticals Inc. Stock Performance

as on April 10, 2026 at 6:08 am IST

  • Day's Low

    Day's High

    $12.52
    $12.94
    downward going graph

    2.64%

    Downside

    0.62%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.69
    $15.42
    downward going graph

    48.02%

    Downside

    19.91%

    Upside

    downward going graph

Amneal Pharmaceuticals Inc. share price movements today

Previous Close
$12.71
Open
$12.60
Volume
654.2K
Day's Low - High
$12.52 - $12.94
52 Week Low - High
$6.69 - $15.42

Amneal Pharmaceuticals Inc. Historical Returns

1 Month Return
-4.08 %
3 Month Return
-1.93 %
1 Year Return
+ 71.06 %
3 Year Return
+ 807.86 %
5 Year Return
+ 113.26 %

Amneal Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Amneal Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.9B

EPS (TTM)

0.9906

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

2.61%

PE Ratio (TTM)

56

Industry PE ratio

15.729518072289157

PEG Ratio

0

EBITDA

644.3M

Revenue (TTM)

3.0B

Profit Margin

2.39%

Return On Equity TTM

-881.26%

Amneal Pharmaceuticals Inc. Stock Valuation

Track how Amneal Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.

Amneal Pharmaceuticals Inc. in the last 5 years

  • Overview

  • Trends

Lowest (2.93x)

March 31, 2023

Industry (15.73x)

April 9, 2026

Today (56.00x)

April 9, 2026

Highest (21.31x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 56.00x

Amneal Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amneal Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Amneal Pharmaceuticals Inc. image
Amneal Pharmaceuticals Inc.
BUY$3.9B113.26%562.39%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$25.5BNA20.8941.94%
Viatris Inc. image
Viatris Inc.
HOLD$15.3B1.31%-21.95-24.58%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$44.0BNA20.1615.11%
Zoetis Inc. image
Zoetis Inc.
BUY$51.5B-25.09%19.6328.24%

Stock Returns calculator for Amneal Pharmaceuticals Inc. Stock including INR - Dollar returns

The Amneal Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Amneal Pharmaceuticals Inc. investment value today

Current value as on today

₹1,85,020

Returns

₹85,020

(+85.02%)

Returns from Amneal Pharmaceuticals Inc. Stock

₹73,082 (+73.08%)

Dollar Impact

₹11,938 (+11.94%)

Analyst Recommendation on Amneal Pharmaceuticals Inc. Stock

Based on 11 analysts

BUY

81.82%

Buy

9.09%

Hold

9.09%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Amneal Pharmaceuticals Inc.. Average target price of $16.8

Amneal Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Amneal Pharmaceuticals Inc..

What analysts predicted

23.45%UPSIDE

Target Price

$16.8

Current Price

$12.86

Analyzed by

11 Analysts

Target

$16.80

Amneal Pharmaceuticals Inc. target price $16.8, a slight upside of 23.45% compared to current price of $12.86. According to 11 analysts rating.

Amneal Pharmaceuticals Inc. Stock’s Investor Sentiment and Interest

Search interest for Amneal Pharmaceuticals Inc. Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:20% versus previous 30 day period

Amneal Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
620
616
659
701
702
730
695
724
784
814
Gross Profit
232
225
238
249
269
262
255
286
273
297
Operating Income
75
14
-10
95
88
75
100
111
0
114
EBITDA
131
33
45
141
139
112
154
176
111
160
Interest Expense
50
59
65
65
65
61
56
65
62
56
Depreciation
57
56
55
55
58
66
60
60
54
49
Income Before Tax
22
-83
-75
20
15
-15
37
51
-5
55
Income Tax Expense
-2
9
6
3
3
5
12
16
-23
5
Net Income
9
-98
-91
5
0
-31
12
22
2
35
Net Profit Margin
1.56%
-15.99%
-13.90%
0.85%
-0.02%
-4.25%
1.75%
3.09%
0.30%
4.31%

Amneal Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,018
1,033
1,662
1,626
1,992
2,093
2,212
2,393
2,793
3,018
Gross Profit
597
526
716
352
628
768
791
863
1,020
1,136
Operating Income
284
245
-19
-248
91
152
-94
204
249
423
EBITDA
306
271
-19
155
345
401
440
500
439
603
Interest Expense
55
71
143
168
145
136
158
210
258
241
Depreciation
-
45
137
207
235
233
240
229
236
223
Income Before Tax
214
171
-202
-220
-35
31
-248
-40
-55
139
Income Tax Expense
5
1
-1
383
-104
11
6
8
18
11
Net Income
207
167
-169
-361
91
10
-129
-83
-116
72
Net Profit Margin
20.37%
16.22%
-10.21%
-22.25%
4.57%
0.51%
-5.88%
-3.51%
-4.18%
2.39%

Amneal Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-93
-81
5
11
-20
24
35
18
49
Operating Cash Flow
135
-4
39
141
118
7
83
118
130
Investing Cash Flow
-31
-19
-6
-20
-16
-17
-26
-22
-45
Financing Cash Flow
-100
-23
-35
-92
-61
-39
-41
59
-10
Change in Cash
3
-47
-1
28
40
-50
15
154
74

Amneal Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
169
-201
-603
91
10
-254
-48
-73
72
Operating Cash Flow
234
250
1
379
241
65
345
295
339
Investing Cash Flow
-98
-396
-19
-317
-194
-174
-69
-62
-112
Financing Cash Flow
-95
287
-45
131
-138
-106
-212
-211
-31
Change in Cash
40
140
-65
194
-90
-221
63
19
194

Global Institutional Holdings in Amneal Pharmaceuticals Inc.

Funds
Holdings
Vanguard Group Inc
5.61%
Nuveen, LLC
1.03%
Goldman Sachs Group Inc
0.71%
Geode Capital Management, LLC
1.28%
D. E. Shaw & Co LP
0.83%
See all

Amneal Pharmaceuticals Inc. News & Key Events

    Insights on Amneal Pharmaceuticals Inc.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 years, AMRX stock has moved up by 807.9%

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, 2.36M → 35.07M (in $), with an average increase of 93.3% per quarter

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 4 quarters, 695.42M → 814.31M (in $), with an average increase of 5.1% per quarter

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, AMRX has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, United Therapeutics Corporation has given 98.7% return, outperforming this stock by 27.6%

    About Amneal Pharmaceuticals Inc.

    an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
    OrganisationAmneal Pharmaceuticals Inc.
    Headquarters400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
    IndustryHealth Technology
    CEOMr. Chirag K. Patel
    E-voting on sharesClick here to vote

    Key Management of Amneal Pharmaceuticals Inc.

    Name

    Title

    Mr. Gregory Sgammato

    Senior Vice President of Corporate Development

    Mr. Pranav Mehta

    Senior VP of Strategic Sourcing & Supply Management

    Mr. Chirag K. Patel

    Co-Founder, Co-CEO, President & Director

    Mr. Chintu Patel R.Ph.

    Co-Founder, Co-CEO & Director

    Mr. Jason B. Daly Esq.

    Executive VP, Chief Legal Officer & Corporate Secretary

    Mr. Anthony DiMeo

    Head of Investor Relations

    Dr. Sanjay Kumar Jain Ph.D.

    Chief Quality Officer

    Mr. Anastasios G. Konidaris

    Executive VP & CFO

    Ms. Nikita Shah

    Executive VP & Chief Human Resources Officer

    Mr. Andrew S. Boyer

    Executive VP and Chief Commercial Officer of Generics & Biosciences

    FAQs

    What is Amneal Pharmaceuticals Inc. share price today?

    Amneal Pharmaceuticals Inc. share price today is $12.86 as on . Amneal Pharmaceuticals Inc. share today touched a day high of $12.94 and a low of $12.52.

    What is the 52 week high and 52 week low for Amneal Pharmaceuticals Inc. share?

    Amneal Pharmaceuticals Inc. share touched a 52 week high of $15.42 on and a 52 week low of $6.69 on . Amneal Pharmaceuticals Inc. stock price today i.e. is trending at $12.86,which is 16.60% down from its 52 week high and 92.37% up from its 52 week low.

    What is Amneal Pharmaceuticals Inc.'s market capitalisation today?

    Amneal Pharmaceuticals Inc. market capitalisation is $0.00T as on .

    How to invest in Amneal Pharmaceuticals Inc. Stock (AMRX) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Amneal Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amneal Pharmaceuticals Inc. Shares that will get you 0.1166 shares as per Amneal Pharmaceuticals Inc. share price of $12.86 per share as on April 10, 2026 at 12:38 am IST.

    What is the minimum amount required to buy Amneal Pharmaceuticals Inc. Stock (AMRX) from India?

    Indian investors can start investing in Amneal Pharmaceuticals Inc. (AMRX) shares with as little as ₹92.637 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹926.37 in Amneal Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Amneal Pharmaceuticals Inc. share’s latest price of $12.86 as on April 10, 2026 at 12:38 am IST, you will get 0.7776 shares of Amneal Pharmaceuticals Inc.. Learn more about fractional shares .

    What are the returns that Amneal Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

    Amneal Pharmaceuticals Inc. stock has given 113.26% share price returns and 24.53% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?